1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6772B9555EC171C6985257E4400615F89
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/772B9555EC171C6985257E4400615F89!OpenDocument
18
19OpenDocument
203.80.128.196
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Business Operations Strategic Planning and Management

Document Excerpt: Benchmarking Advisory Board Management at Large Pharmaceutical & Medical Device Organizations: Cost and Challenges

DB Image

ID: MD-466


Features:

8 Info Graphics

20 Data Graphics

330+ Metrics

11 Narratives


Pages/Slides: 4


Published: 2015


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".


To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5363 "Benchmarking Advisory Board Management at Large Pharmaceutical & Medical Device Organizations: Cost and Challenges."


Industries Profiled:
Health Care; Medical Device; Diagnostic; Academic; Research; Education; Science; Pharmaceutical; Biopharmaceutical; Consulting; Biotech; Manufacturing; Consumer Products; Clinical Research; Laboratories


Companies Profiled:
Novo Nordisk; Articulate Labs; MD Outlook; Duke University and Health System; B. Braun; Reliance Institute of Life Sciences; PharMedium; Catalent Pharma Solutions; Poxel; Medicines Differentiation Analytics; Uroplasty; cipla; Medunik Canada; Purdue Pharma; Lupin; Acorda Therapeutics; Avanir; Haemonetics Corporation; Biogen Idec; Xenoport; Abbott Nutrition; Boehringer Ingelheim; Bayer; Sanofi; UCB Pharma; Covidien; AstraZeneca; Abbvie; Teva Pharmaceutical Industries Ltd


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.